Fund moves

Charles River Laboratories (CRL): Earnest Partners LLC reduced its stake -17K shares

Earnest Partners LLC reduced its stake in Charles River Laboratories, per its Q1 2026 13F.

971K
Shares reported · -17K vs prior quarter
0.69%
Disclosed portfolio weight
$168M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Feb 25, 2026Federal contract · $936K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $936K obligated to date
  2. Feb 28, 2026Federal contract · $5.3M obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $5.31M obligated to date
  3. Mar 26, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  4. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.4%
  5. May 5, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote“On May 5, 2026, Charles River Laboratories International, Inc. (the “Company”) held its 2026 annual meeting of shareholders (the “Annual Meeting”). As further discussed below, at the Annual Meeting, the shareholders of the Company approved the Company’s 2026 Long-Term Incentive Plan (the “2026 Incentive Plan”).”
  6. May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 7.0%
  7. May 6, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 4.9%
  8. May 7, 2026Company filing · Form 8-K · ResultsReported its results

What came next

  1. Jun 1, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
  2. Jun 1, 2026Federal contract · $340K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $340K obligated to date
  3. Jun 29, 2026Insider · Their largest sale since 2006Director sold ~$16.9M of CRL shares in the open market
  4. Aug 5, 2026Company filing · Form 8-K · ResultsReported its results
  5. Aug 5, 2026Insider · Their largest sale since 2022Officer sold ~$1.33M of CRL shares in the open market
  6. Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 8.8%
  7. Aug 6, 2026Insider · 2 peopleInsiders: 10 sales (~$2.8M)
  8. Aug 10, 2026InsiderDirector sold ~$7.9M of CRL shares in the open market
  9. Aug 11, 2026Insider · 2 peopleInsiders: 2 sales (~$2.9M)
  10. Aug 13, 20265% stakeInvesco Ltd. reported a passive stake (13G) of 6.2%
  11. Aug 18, 2026Federal contract · $372K obligatedDepartment of Health and Human Services awarded Charles River Laboratories: $372K obligated to date
  12. Aug 18, 2026InsiderDirector sold ~$163K of CRL shares in the open market
  13. Aug 19, 2026InsiderOfficer sold ~$600K of CRL shares in the open market
  14. Aug 25, 2026InsiderDirector sold ~$10.1M of CRL shares in the open market
  15. Sep 8, 20265% stakeFMR LLC reported a passive stake (13G) of 10.2%
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Charles River Laboratories

For Charles River Laboratories, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CRL page.

How this filing works

Explore the data

Common questions

What does this filing report about Charles River Laboratories (CRL) stock?

Earnest Partners LLC reduced its stake in Charles River Laboratories, per its Q1 2026 13F. Now 971K shares, $168M reported value, 0.69% of disclosed portfolio.

When did it happen, and when was it made public?

Holdings as of: Mar 31, 2026. Filed: May 15, 2026.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Form 13F-HR, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Charles River Laboratories recently?

For Charles River Laboratories, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 2 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days. They are listed on the CRL page.

Does this mean CRL stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Charles River Laboratories

Everything OQRO holds on this company is on its CRL page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data